Related and Nonrelated Parties [Axis] Related Party [Member] Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Product and Service [Axis] Product [Member] Consulting Fees [Member] Equity Components [Axis] Preferred Stock [Member] Series A Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Series B Preferred Stock [Member] Business Combination [Axis] Green C Corporation [Member] Class A Common Stock [Member] Title and Position [Axis] Former Share Holders [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Licensing Agreement [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Kol Tuv Ventures, LLC [Member] Right Of First Refusal Agreement [Member] CBD [Member] Elisha Kalfa and Yonah Kalfa [Member] Aitan Zacharin [Member] Fernando Bisker and Sigalush LLC [Member] Loan and Contribution Agreements [Member] Debt Instrument [Axis] Promissory Note [Member] Convertible Promissory Note [Member] John T. Root [Member] FirstFire Global Opportunities Fund, LLC [Member] Vesting [Axis] Share-Based Payment Arrangement, Tranche One [Member] FirstFire Note [Member] FirstFire Note One [Member] FirstFire Note Two [Member] Second FirstFire Note [Member] Scenario [Axis] Less than or Equal to 30 Days [Member] FF Note [Member] 31 - 60 Days [Member] 61 - 90 Days [Member] 91 - 120 Days [Member] 121 - 150 Days [Member] 151 - 180 Days [Member] Measurement Input Type [Axis] Measurement Input, Share Price [Member] Measurement Input, Conversion Price [Member] Measurement Input, Expected Term [Member] Measurement Input, Price Volatility [Member] Measurement Input, Risk Free Interest Rate [Member] Common Class A [Member] Legal Entity [Axis] Emet Capital Partners, LLC [Member] Chief Executive Officer [Member] Sylios Corp [Member] Two Consulting Firm Entities [Member] Two Exchange Agreement [Member] Second Exchange Agreement [Member] Convertible Notes [Member] Notes Payable [Member] Warrant A [Member] Warrant B [Member] Warrant C [Member] Exclusive License Agreement [Member] Pharmedica Ltd [Member] Sub License Agreement [Member] Symtomax Unipessoal IDA [Member] Services Agreements [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] CURRENT ASSETS Cash Total current assets OTHER ASSETS Right of first refusal agreement cost (less accumulated amortization of $25,000 and $25,000) Total assets LIABILITIES AND STOCKHOLDERS’ DEFICIENCY CURRENT LIABILITIES Accounts payable Accrued officers’ compensation Loans payable to related parties Total current liabilities and total liabilities STOCKHOLDERS’ (DEFICIENCY) Preferred shares value Common stock; 2,000,000,000 shares authorized, $.001 par value, as of June 30, 2026 and December 31, 2025, there are 994,379 and 944,935 shares outstanding, respectively Additional paid-in capital Accumulated deficit Total stockholders’ (deficiency) Total liabilities and stockholders’ (deficiency) Accumulated amortization Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Common shares issued not disclosed Common stock, shares authorized Common stock, par value Common stock, shares outstanding Revenue: Total revenue Cost of product sales Gross profit (loss) Operating Expenses: Officers compensation Stock-based compensation Amortization of Right of First Refusal Agreement cost Other operating expenses Total operating expenses Income (loss) from operations Other income (expenses): Gain on cancellation of debt Gain on cancellation of preferred stock A Interest expense Note default penalties and interest Loss on conversion of notes payable Total other income (expenses) Income (loss) before provision for income taxes Provision for income taxes Net income (loss) Basic income (loss) per common share Diluted income (loss) per common share Weighted average common shares outstanding-basic Weighted average common shares outstanding-diluted Balance Balance, shares Issuance of common stock for notes payable conversion Issuance of common stock for notes payable conversion, shares Issuance of common stock for accrued compensation Issuance of common stock for accrued compensation, shares Cancellation of preferred stock A Cancellation of preferred stock A, shares Issuance of preferred stock A Issuance of preferred stock A, shares Net income (loss) Balance Balance, shares Cancellation of preferred stock A Issuance of common stock for accrued compensation Issuance of common stock for accrued compensation, shares Conversion of common stock for notes payable Issuance of stock for compensation Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Adjustments to reconcile net income (loss) to net cash provided (used) in operating activities: Issuance of common stock for compensation Issuance of common stock for accrued compensation Loss on conversion of notes Note default penalties and interest Gain on cancellation of debt Gain on cancellation of preferred stock A Changes in operating assets and liabilities: Accounts payable Accrued interest Accrued officers’ compensation Net cash used in operating activities INVESTING ACTIVITIES Net cash used in investing activities FINANCING ACTIVITIES Proceeds from notes payable to related party Net cash provided by financing activities NET (DECREASE) IN CASH CASH BALANCE, BEGINNING OF PERIOD CASH BALANCE, END OF PERIOD Supplemental Disclosures of Cash Flow Information: Interest paid Income tax paid Accounting Policies [Abstract] NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] GOING CONCERN Commitments and Contingencies Disclosure [Abstract] RIGHT OF FIRST REFUSAL AGREEMENT Related Party Transactions [Abstract] LOANS PAYABLE TO RELATED PARTIES Debt Disclosure [Abstract] NOTES PAYABLE TO THIRD PARTIES Derivative Instruments and Hedging Activities Disclosure [Abstract] DERIVATIVE LIABILITY Equity [Abstract] CAPITAL STOCK AND WARRANTS Income Tax Disclosure [Abstract] INCOME TAXES COMMITMENTS AND CONTINGENCIES Restatement Of Previously Issued Financial Statements RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS Subsequent Events [Abstract] SUBSEQUENT EVENTS Nature of Operations Principles of Consolidation Interim Financial Statements Cash and Cash Equivalents Notes and Accounts Receivable Income Taxes Use of Estimates Financial Instruments and Fair Value of Financial Instruments Derivative Liabilities Long-lived Assets Equity Instruments Issued to Non-Employees for Acquiring Goods or Services Related Parties Revenue Recognition Advertising Costs Loss per Share Recently Enacted Accounting Standards SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES SCHEDULE OF NOTES PAYABLE TO THIRD PARTIES SCHEDULE OF PREPAY AMOUNT AND DATE DESCRIPTION SCHEDULE OF DERIVATIVE LIABILITY Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Percentage of issued and outstanding shares acquired Number of shares issued Common stock, voting rights Licensing fee Increase in licensing fee Milestone payments Milestone payments on initiation of clinical trial Milestone payments on first regulatory approval Royalty payment description Sublicense royalty percentage Reverse stock split Cash equivalents Uncertain tax positions Cash Liabilities, current Working capital deficit Net loss from operations Cash used from operating activities Product Liability Contingency [Table] Product Liability Contingency [Line Items] Payment for other investment opportunities Amortization cost Related Party Transaction [Table] Related Party Transaction [Line Items] Total Total number of shares convertible Repayments of related party debt Short-Term Debt [Table] Short-Term Debt [Line Items] Total Debt instrument, interest rate Debt instrument maturity date Conversion price Unamortized discount Debt instrument, principal amount Proceeds from issuance of convertible debt Debt conversion, original issue discount PREPAY AMOUNT Shares issued for conversion Principal amount Debt default, description Debt default, description of event of default Debt repayment percentage Accrued but unpaid default Interest and penalties Issuance of warrants DerivativeLiabilityTable [Table] Total derivative liability Derivative liability measurement input Derivative liability, measurement input, term Stock, Class of Stock [Table] Class of Stock [Line Items] Business acquisition, percentage of voting interests acquired Stock issued new issues Preferred stock, conversion basis Debt instrument, convertible, conversion price Conversion of stock, shares converted Unpaid compensation Debt instrument, interest rate, percentage Common stock, shares held Number of shares issued Debt instrument, face amount Interest payable Excess of common stock value Fair value of common stock Loss on conversion of debt Number of warrant issued Exercise price of warrants Number of shares issued for services Fair value of shares charged to other operating expenses Number of shares charged to other operating expenses Fair value of common stock Debt instrument, periodic payment Debt instrument, interest rate, percentage Debt convertible threshold trading days Excess of fair value Liability reduction Notes payable Debt conversion, original debt, amount Value of shares issued for compensation Number of shares issued for compensation Issuance of common stock for accrued compensation, shares Accrued compensation par value Issuance of common stock for accrued compensation, value Reverse stock split shares Common Stock, Par or Stated Value Per Share Warrant purchase of common stock Warrants issued value Loss Contingencies [Table] Loss Contingencies [Line Items] Cost, direct tax and license Annual royalties rate Royalty expense Asset impairment charges Intangible assets, net Forgiveness of royalty payable Accrued royalties Payments for royalties Note default penalties and interest Kol Tuv Ventures, LLC [Member] Right Of First Refusal Agreement [Member] CBD [Member] Elisha Kalfa and Yonah Kalfa [Member] Series A Convertible Preferred Stock [Member] Fernando Bisker and Sigalush LLC [Member] Common stock shares issued not disclosed. Loan and Contribution Agreements [Member] Promissory Note [Member] John T. Root [Member] Convertible Promissory Note [Member] FirstFire Global Opportunities Fund, LLC [Member] Series B Convertible Preferred Stock [Member] FirstFire Note [Member] FirstFire Note One [Member] FirstFire Note Two [Member] = 30 days [Member] FF Note [Member] 31 - 60 Days [Member] 61 - 90 Days [Member] 91 - 120 Days [Member] 121 - 150 Days [Member] 151 - 180 Days [Member] Debt repayment percentage. Second FirstFire Note [Member] Derivative liability fair value assumptions expected term. Green C Corporation [Member] Emet Capital Partners, LLC [Member] Stock issued during period value of unpaid compensation. Sylios Corp [Member] Common stock, shares held. Excess of common stock value. Fair value of common stock. Loss on conversion of note payable and accrued interest to common stock. Warrant issued. Two Consulting Firm Entities [Member] Fair value of shares charged to other operating expenses. Number of shares charged to other operating expenses. Two Exchange Agreement [Member] Second Exchange Agreement [Member] Convertible Notes [Member] Excess of fair value. Liability reduction. Notes Payable [Member] Stock issued during period shares issuance of common stock for compensation shares. Accrued compensation par value. Stock issued during period value issuance of common stock for compensation shares. Warrant A [Member] Warrant B [Member] Warrant C [Member] Exclusive License Agreement [Member] Annual royalties rate. Pharmedica Ltd [Member] Forgiveness of royalty payable. Sub license agreement [Member] Symtomax unipessoal lda [Member] Services agreements [Member] Restatement of Previously Issued Financial Statements [Text Block] Note default penalties default interest. Gain on cancellation of debt. Gain on cancellation of preferred stock. Aitan Zacharin [Member] Issuance of common stock for accrued compensation. Class A Common Stock [Member] Former Share Holders [Member] Licensing fee. Licensing Agreement [Member] Milestone payments. Increase decrease in licensing fee. Milestone payments on initiation of clinical trial. Milestone payments on first regulatory approval. Royalty payment description. Sublicense royalty percentage. Interim Financial Statements [Policy Text Block] Related Parties [Policy Text Block] Working capital deficit. Consulting Fees [Member] Nature Of Operations [Policy Text Block] Assets, Current Assets Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Nonoperating Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Stock Issued During Period, Value, Issued for Services IssuanceOfCommonStockForAccruedCompensation Increase (Decrease) in Accounts Payable Increase (Decrease) in Employee Related Liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Cash and Cash Equivalent Working capital deficit Notes Payable, Current StockIssuedDuringPeriodSharesIssuanceOfCommonStockForCompensationShares Debt Instrument, Debt Default, Amount